Precision medicine in diabetes: A non‐invasive prenatal diagnostic test for the determination of fetal glucokinase mutations

Precision medicine in diabetes: A non‐invasive prenatal diagnostic test for the determination of fetal glucokinase mutations

ABSTRACT Hyperglycemia caused by mutations in the glucokinase gene, GCK, is the most common form of monogenic diabetes. Prenatal diagnosis is important, as it impacts on treatment. This study reports a monogenic non‐invasive prenatal diagnostic (NIPD‐M) test on cell‐free DNA in maternal plasma using...

Full description

Bibliographic Details
Main Authors: Thierry Nouspikel, Jean‐Louis Blouin, Jardena J Puder, Bettina Köhler Ballan, Valerie M Schwitzgebel
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of Diabetes Investigation
Subjects:
Fetal DNA
Monogenic diabetes
Precision medicine
Online Access:https://doi.org/10.1111/jdi.13656

Similar Items

Similar Items